Renalyse
2 known investors
Renalyse is developing a point-of-care device for measuring creatinine and potassium in blood, intended as part of a platform for remote renal monitoring. It targets chronic kidney disease (CKD) management by connecting patients with healthcare professionals to provide real-time patient data to doctors.
Investors Β· 2
Frequently asked questions
- What does Renalyse do?
- Renalyse is developing a point-of-care device for measuring creatinine and potassium in blood, intended as part of a platform for remote renal monitoring. It targets chronic kidney disease (CKD) management by connecting patients with healthcare professionals to provide real-time patient data to doctors.
- Who are Renalyse's investors?
- Renalyse's investors include BStartup, Ship2B.